Search

VIRIDIAN THERAPEUTICS INC

Slēgts

SektorsVeselības aprūpe

23.06 -3.07

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

22.99

Max

23.88

Galvenie mērījumi

By Trading Economics

Ienākumi

-22M

-127M

Pārdošana

143K

284K

EPS

-1.05

Peļņas marža

-44,760.211

Darbinieki

252

EBITDA

-24M

-125M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+42.38% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

589M

2.7B

Iepriekšējā atvēršanas cena

26.13

Iepriekšējā slēgšanas cena

23.06

Ziņu noskaņojums

By Acuity

50%

50%

145 / 340 Rangs Healthcare

VIRIDIAN THERAPEUTICS INC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 27. aug. 22:01 UTC

Viridian Therapeutics Inc shares are lower in after-market hours, reflecting notable weakness following a flat start to the session. No specific news was identified.

2026. g. 25. aug. 20:07 UTC

Viridian Therapeutics is gaining amid a broader positive market trend, despite earlier pulling back from a session high. Shares remain above the 20-day moving average.

2026. g. 24. aug. 19:26 UTC

Viridian Therapeutics Inc is declining during Monday's session, continuing a trend of lower performance over the past three days amid geopolitical and inflation concerns.

2026. g. 21. aug. 23:21 UTC

Viridian Therapeutics Inc. shares advanced in after-market trading, continuing a strong one-month performance and remaining above the 20-day moving average.

2026. g. 20. aug. 22:56 UTC

Viridian Therapeutics Inc. shares declined in after-hours trading, reflecting broader market trends amid concerns about consumer spending and inflation pressures.

2026. g. 19. aug. 23:01 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, reflecting positive market sentiment amid broader gains and strong performance in cryptocurrency values.

2026. g. 17. aug. 20:06 UTC

Viridian Therapeutics Inc shares rose significantly since Friday's close, reaching a peak increase in late morning trading, though no specific news was identified.

2026. g. 14. aug. 19:56 UTC

Viridian Therapeutics is trading higher, recovering from an earlier dip, as broader market sentiment reacts to a surprise decline in U.S. retail sales.

2026. g. 13. aug. 19:56 UTC

Correlated Moves

Viridian Therapeutics Inc shares declined again, marking five consecutive lower closes, amid broader weakness in the biotechnology sector and rising unemployment claims.

2026. g. 11. aug. 19:46 UTC

Viridian Therapeutics Inc shares are lower today amid broader market declines following a weak jobs report, influencing expectations for Federal Reserve policy.

2026. g. 7. aug. 20:05 UTC

Correlated Moves
News

Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.

2026. g. 6. aug. 21:02 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.

2026. g. 5. aug. 23:02 UTC

Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.

2026. g. 4. aug. 21:02 UTC

Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.

2026. g. 3. aug. 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reaching their lowest point despite a prior period of stability. No specific news was identified.

2026. g. 31. jūl. 20:02 UTC

Viridian Therapeutics Inc's shares are lower today, breaking a trend of higher closes. Broader market factors, including rising Treasury yields, may be influencing this shift.

2026. g. 30. jūl. 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, following earlier stability. Broader market uncertainty over the Federal Reserve's rate decision persists.

2026. g. 29. jūl. 23:56 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

2026. g. 28. jūl. 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reversing an initial uptick amid cautious broader market sentiment and declines in technology shares.

2026. g. 27. jūl. 19:26 UTC

Viridian Therapeutics Inc is trading higher, maintaining strength since Friday's close and reflecting positive momentum near the upper end of its one-month trading range.

2026. g. 24. jūl. 17:36 UTC

Viridian Therapeutics shares are higher since Thursday's close, recovering from earlier lows. Broader market sentiment improved amid declining crude oil prices.

2026. g. 22. jūl. 19:26 UTC

Viridian Therapeutics Inc is trading higher during Wednesday's session, recovering from earlier lows despite the broader market's mixed performance.

2026. g. 21. jūl. 19:51 UTC

Correlated Moves

Viridian Therapeutics Inc shares are trading higher, reflecting strong intraday performance. The move aligns with positive sentiment in the biotechnology sector.

2026. g. 20. jūl. 19:01 UTC

Viridian Therapeutics Inc is advancing in Monday's session, despite earlier pullback. No specific company news was identified to explain the price movement.

Salīdzinājums

Cenas izmaiņa

VIRIDIAN THERAPEUTICS INC Prognoze

Cenas mērķis

By TipRanks

42.38% augšup

Prognoze 12 mēnešiem

Vidējais 34 USD  42.38%

Augstākais 41 USD

Zemākais 22 USD

Pamatojoties uz 13 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi VIRIDIAN THERAPEUTICS INC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

13 ratings

13

Pirkt

0

Turēt

0

Pārdot

Noskaņojums

By Acuity

145 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Vidējais

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

help-icon Live chat